ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 452,42
-0,49%
Dow Jones
42 635,20
0,25%
DAX
20 329,94
-0,10%
Brent Oil
75,595
-0,52%
Bitcoin
95 005,19
-0,05%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Nymox Pharmaceutical Corp (NYMX)

  7. Nymox Pharmaceutical Corp (NYMX) Actualités

NYMX

Nymox Pharmaceutical (NYMX)

Nymox Pharmaceutical Corp
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:NYMX
DateHeureSourceTitreSymboleSociété
29/08/202423h26Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:NYMXNymox Pharmaceutical Corp
13/05/202422h06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
08/09/202316h13Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NYMXNymox Pharmaceutical Corp
25/07/202316h33GlobeNewswire Inc.Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial ResultsNASDAQ:NYMXNymox Pharmaceutical Corp
18/07/202316h45GlobeNewswire Inc.Nymox Reports on U.S. Patent IssuancesNASDAQ:NYMXNymox Pharmaceutical Corp
13/07/202316h16GlobeNewswire Inc.Nymox UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
12/07/202315h30GlobeNewswire Inc.Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of NymoxNASDAQ:NYMXNymox Pharmaceutical Corp
07/07/202323h02GlobeNewswire Inc.NYMOX UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
06/07/202300h11GlobeNewswire Inc.Nymox Delisting from NASDAQNASDAQ:NYMXNymox Pharmaceutical Corp
29/06/202323h15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NYMXNymox Pharmaceutical Corp
29/06/202322h25Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:NYMXNymox Pharmaceutical Corp
29/06/202322h24Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:NYMXNymox Pharmaceutical Corp
26/06/202316h28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:NYMXNymox Pharmaceutical Corp
10/05/202316h00GlobeNewswire Inc.Nymox Provides Current UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
03/04/202315h30GlobeNewswire Inc.Nymox Provides Corporate UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
31/03/202322h25Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NASDAQ:NYMXNymox Pharmaceutical Corp
21/03/202315h00GlobeNewswire Inc.Nymox Announces Appointment of Christopher R. Riley as Chief Financial OfficerNASDAQ:NYMXNymox Pharmaceutical Corp
15/03/202314h30GlobeNewswire Inc.Nymox Officially Granted Extension to Regain Listing RequirementsNASDAQ:NYMXNymox Pharmaceutical Corp
15/02/202317h50GlobeNewswire Inc.Nymox Announces NYMOZARFEX Marketing Application is Accepted For ReviewNASDAQ:NYMXNymox Pharmaceutical Corp
06/01/202322h30GlobeNewswire Inc.NYMOX Appeals Deficiency LetterNASDAQ:NYMXNymox Pharmaceutical Corp
05/12/202215h30GlobeNewswire Inc.NYMOX Announces New Marketing Submission for NYMOZARFEX™ for BPHNASDAQ:NYMXNymox Pharmaceutical Corp
25/11/202221h10GlobeNewswire Inc.May 2023 Market Cap Requirement UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
13/09/202215h30GlobeNewswire Inc.NYMOX Provides Current UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
15/07/202215h30GlobeNewswire Inc.NYMOX Updates ShareholdersNASDAQ:NYMXNymox Pharmaceutical Corp
14/07/202218h18GlobeNewswire Inc.NYMOX Receives Deficiency Letter from NASDAQNASDAQ:NYMXNymox Pharmaceutical Corp
23/05/202214h30GlobeNewswire Inc.NYMOX Receives RTF letter from FDANASDAQ:NYMXNymox Pharmaceutical Corp
06/05/202212h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NYMXNymox Pharmaceutical Corp
13/04/202212h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NYMXNymox Pharmaceutical Corp
04/04/202215h45GlobeNewswire Inc.Nymox Announces Closing of $6.4 Million FinancingNASDAQ:NYMXNymox Pharmaceutical Corp
22/03/202219h57Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:NYMXNymox Pharmaceutical Corp
 Showing the most relevant articles for your search:NASDAQ:NYMX

Dernières Valeurs Consultées

EU
MC
Lvmh Moet Hennessy Louis...
NYSE
DIS
Walt Disney
EU
CS
Axa
NYSE
JPM
JP Morgan Chase
FTSE
UKX
FTSE 100
NYSE
MRK
Merck
EU
GLE
Societe Generale
EU
SGO
Cie de SaintGobain
COIN
SOLUSD
Solana
EU
DG
Vinci
EU
ORA
Orange
EU
BNP
BNP Paribas
EU
HO
Thales
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés